Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IP Group PLC Director's Dealing 2026

Apr 23, 2026

4852_dirs_2026-04-23_3a635a1b-aee0-4b1b-b771-43daaad40014.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 7025B

IP Group PLC

23 April 2026

FOR RELEASE ON # 23 April 2026

IP Group plc - Employee Share Schemes; Director/PDMR shareholding

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces the following in connection with its employee share schemes.

Release of Deferred Bonus Awards

On 22 April 2026, the Group's executive directors and one other person discharging managerial responsibilities ("PDMR") received a total of 168,957 ordinary shares of two pence each ("Shares"), resulting from the release of Deferred Bonus Awards granted in relation to the partial deferral of annual bonuses for the 2023 and 2024 financial years. 

The delivery of the awards was satisfied through the transfer of Shares from the Company's employee benefit trust (the "EBT"), with the balance being settled by cash payments in an amount sufficient to meet the relevant individuals' income and other tax liabilities in accordance with the rules of the IP Group Share Plan ("Share Plan"). 

The Shares transferred to the Group's executive directors will be held by the EBT on behalf of, and as nominee for, the executive directors in order to facilitate the application of the Group's Post Cessation Shareholding Policy.

A copy of the Share Plan can be found at:

https://www.ipgroupplc.com/investors/corporate-governance

Shares in issue

As at 22 April, the Company had 883,427,642 Shares in issue and no Shares held in treasury.

The following information is being disclosed pursuant to the requirements of MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

DBA Release

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Greg Smith

David Baynes

Mark Reilly

2

Reason for the notification

a)

Position/status

Director        Chief Executive Officer

Director        Chief Operating and Financial Officer

PDMR          Managing Partner

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

Nature of the transaction

Release of the 2024 Deferred Bonus Awards and 2025 Deferred Bonus Awards

c)

Currency

GBP

d)

Price(s) and volume(s)

Name(s) Price(s) Volume(s)
Greg Smith Conditional Share Award 67,116
David Baynes Conditional Share Award 41,435
Mark Reilly Conditional Share Award 60,406

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

168,957

63.7p

£107,625.61

f)

Date of the transaction

22 April 2026

g)

Place of the transaction

London Stock Exchange, Main Market

For more information, please contact:

IP Group plc www.ipgroupplc.com
Liz Vaughan-Adams, Communications   

Portland

Alex Donaldson
+44 (0) 20 7444 0062/+44 (0) 7979 853802

+44 (0) 7516 729702

Notes for editors

About IP Group

IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science and technology investor, we develop and support some of the world's most exciting businesses in healthtech, deeptech and cleantech. Including through Parkwalk, the UK's largest growth EIS fund manager, we back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, Hinge Health, Featurespace, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

For more information, please visit our website at www.ipgroupplc.com.

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHPPUAGCUPQGGW